US EditionPublished • loading... • Updated
h2o Therapeutics Receives European MDR Certification for Its Apple Watch-Based App for Parkinson’s Disease
Summary by ecnetnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
h2o Therapeutics Receives European MDR Certification for Its Apple Watch-Based App for Parkinson’s Disease
Press Release • May 30, 2025 17:45 +03 ANKARA, Turkey, May 30, 2025 (Ecnetnews.com) – h2o Therapeutics announced that it has received European Union Medical Device Regulation (EU MDR) Class IIa certification for Parky, a mobile app designed to monitor and manage Parkinson’s Disease (PD) symptoms via Apple Watch. This follows the 510(k) clearance previously granted by the U.S. Food and Drug Administration (FDA) in 2022, making Parky one of the …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
